49 studies found for:    "Spinal muscular atrophy"
Show Display Options
Rank Status Study
21 Active, not recruiting An Open-label Safety and Tolerability Study of ISIS SMNRx in Patients With Spinal Muscular Atrophy Who Previously Participated in ISIS 396443-CS1
Condition: Spinal Muscular Atrophy
Intervention: Drug: ISIS-SMNRx
22 Enrolling by invitation An Open-label Safety and Tolerability Study of ISIS SMNRx in Patients With Spinal Muscular Atrophy Who Previously Participated in ISIS SMNRx-CS2 or ISIS SMNRx-CS10
Condition: Spinal Muscular Atrophy
Intervention: Drug: ISIS-SMNRx
23 Recruiting Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development
Condition: Spinal Muscular Atrophy (SMA)
Intervention:
24 Active, not recruiting Clinical Study of Spinal Muscular Atrophy
Condition: Spinal Muscular Atrophy
Intervention:
25 Completed A Trial of Hydroxyurea in Spinal Muscular Atrophy
Condition: Spinal Muscular Atrophy
Intervention: Drug: Hydroxyurea
26 Recruiting Valproate and Levocarnitine in Children With Spinal Muscular Atrophy
Condition: Spinal Muscular Atrophy
Interventions: Drug: Valproate, Levocarnitine;   Drug: Placebo
27 Completed Evaluation of the Muscle Strength and Motor Ability in Children With Spinal Muscle Atrophy(SMA) Treated With Valproic Acid
Condition: Spinal Muscular Atrophy
Intervention:
28 Unknown  Motor Development and Orthoses in Spinal Muscular Atrophy (SMA)
Condition: Spinal Muscular Atrophy
Intervention:
29 Completed Measuring Levels of SMN in Blood Samples of SMA Patients
Condition: Spinal Muscular Atrophy
Intervention:
30 Completed Phase II Study of Leuprolide and Testosterone for Men With Kennedy's Disease or Other Motor Neuron Disease
Conditions: Spinal Muscular Atrophy;   Amyotrophic Lateral Sclerosis;   Spinobulbar Muscular Atrophy
Interventions: Drug: leuprolide;   Drug: testosterone
31 Completed SMN Copy Number Distribution in Mali, West Africa
Condition: Spinal Muscular Atrophy
Intervention:
32 Unknown  Establishing Novel Detection Techniques for Various Genetic-Related Diseases by Applying DHPLC Platform.
Conditions: Spinal Muscular Atrophy;   Neonatal Hyperbilirubinemia;   Colon Cancer
Intervention:
33 Unknown  Quantitative Analysis of SMN1 and SMN2 Gene Based on DHPLC System
Condition: Spinal Muscular Atrophy
Intervention:
34 Withdrawn Multi-disease Carrier Screening Test Validation
Conditions: Spinal Muscular Atrophy (SMA);   Carrier Screening;   Genetic Testing
Intervention: Procedure: Blood draw
35 Completed A Pilot Therapeutic Trial Using Hydroxyurea in Type I Spinal Muscular Atrophy Patients
Condition: Muscular Atrophy, Spinal
Intervention: Drug: Hydroxyurea
36 Unknown  A Pilot Therapeutic Trial Using Hydroxyurea in Type II and Type III Spinal Muscular Atrophy Patients
Condition: Muscular Atrophy, Spinal
Intervention: Drug: Hydroxyurea
37 Active, not recruiting
Has Results
Progressive Strength Training in Spinal Muscular Atrophy
Condition: Muscular Atrophy, Spinal
Intervention: Other: Progressive strength training
38 Unknown  Flu Vaccine Study in Neuromuscular Patients 2011
Conditions: Duchenne Muscular Dystrophy;   Spinal Muscular Atrophy;   Congenital Muscular Dystrophy
Intervention: Biological: 2011-2012 seasonal flu vaccine
39 Completed Optimum Insufflation Capacity in NMD
Conditions: Duchenne Muscular Dystrophy;   Spinal Muscular Atrophy;   Chronic Respiratory Insufficiency
Interventions: Procedure: IPPB;   Procedure: LIAM
40 Unknown  Effects of Power Mobility on Young Children With Severe Motor Impairments
Conditions: Cerebral Palsy;   Arthrogryposis;   Spinal Muscular Atrophy;   Other Central Nervous System or Musculoskeletal Disorders
Interventions: Other: Power mobility;   Other: No intervention

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-49) Show next page of results
Indicates status has not been verified in more than two years